|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization | |||||
| Amortization and accretion of investments, net | |||||
| Noncash lease expense | |||||
| Inventory write-down | |||||
| (Gain) loss on impairment and disposal of assets | |||||
| Gain on disposal of assets, including assets held for sale | |||||
| Share-based compensation | |||||
| Provision for doubtful accounts | |||||
| Acquired in-process research and development (Note 2) | |||||
| Carrying value adjustment to assets held for sale | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other liabilities | |||||
| Operating lease liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities | |||||
| Purchase of property and equipment | |||||
| Proceeds from sale of property and equipment | |||||
| Purchase of in-process research and development | |||||
| Payments for security deposit, net | |||||
| Payments for security deposit | |||||
| Receipt of security deposit | |||||
| Purchase of investments | |||||
| Proceeds from sale and maturity of investments | |||||
| Net cash provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from exercise of common stock options | |||||
| Taxes paid related to net share settlement of equity awards | |||||
| Repurchase of treasury stock | |||||
| Net cash used in financing activities | |||||
| Net increase (decrease) in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash, beginning of period | |||||
| Cash and cash equivalents and restricted cash, end of period | |||||
Loading...